Aubrey de Grey

CAREER

• His original field was computer science.
• He did research in the private sector for 6 years in the area of software verification before switching to biogerontology in the mid-1990s. 
• He sits on the editorial and scientific advisory boards of numerous journals and organizations.
• He is a sought-after speaker who gives at least 40 talks per year in areas ranging from pharma to life insurance.
  

SENS

• Dr. de Grey believes that aging can be treated as a disease that can be cured.
• He developed a comprehensive plan for such repair, named Strategies for Engineered Negligible Senescence (SENS).
• SENS breaks aging down into seven major classes of damage and identifies detailed approaches to addressing each one.
• SENS can potentially extend a healthy lifespan without limit, even though these repair processes will probably never be perfect.
• The repair only needs to approach perfection rapidly enough to keep the overall level of damage below pathogenic levels.

RESEARCH INTERESTS

• pathogenic cellular and molecular damage in mammalian aging
  
• design of interventions to reverse the age-related accumulation of such damage

CURRENT APPOINTMENTS

• Co-Founder and Scientific Advisor of the Methuselah Foundation
  
• Vice President of New Technology Discovery of AgeX Therapeutics
• Associate Professor at the Moscow Institute of Physics and Technology
  
• Editor-in-Chief of Rejuvenation Research
• Fellow of the Gerontological Society of America 
  
• Fellow of the American Aging Association
• Member of the Gerontological Society of America 
  
• Member of the Institute for Ethics and Emerging Technologies